Home About Us Locations Services Your Visit Forms Patient

Evanston and Chicago Allergy Resources

American Academy of Allergy Asthma and Immunology
American College of Allergy, Asthma and Immunology

Allergic Rhinitis


Asthma and Allergy Foundation of America
National Institute of Health - Asthma Resources for Kids
Allergy and Asthma Network - Mothers of Asthmatics
Children: Is your asthma controlled? Take this test!
Adults: Is your asthma controlled? Take this test!

Food Allergy

Current US Food Allergy Guidelines
Food Allergy Research and Education
Mothers of Children Having Allergies
Kids With Food Allergies
Traveling with Food Allergies
Medical ID Bracelet


Overview of Sinusitis
Sinus Rinse | Netipot - It works!

Venom Allergy (bee/wasp sting)

Stinging Insect Facts

Skin Conditions

Drug Allergy

Eosinophilic Gastrointestinal Disorders

American Partnership for Eosinophilic Disorders

Immune Deficiency

Immune Deficiency Foundation

Celiac Disease and Gluten Sensitivity

University of Chicago - Celiac Disease Center

Catch up on the latest allergy news from MedWorm.com

As-Needed Inhaler Use an Option for Children With Mild Asthma
FRIDAY, Aug. 23, 2019 -- Children with mild asthma can use inhalers as needed, according to a study published online July 30 in the Journal of Allergy and Clinical Immunology: In Practice. Kaharu Sumino, M.D., from the Washington University School... (Source: Drugs.com - Pharma News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

AstraZeneca Imfinzi Combination Fails Advanced Lung Cancer Study AstraZeneca Imfinzi Combination Fails Advanced Lung Cancer Study
A combination of AstraZeneca's lung cancer drug Imfinzi and an experimental treatment failed to extend the lives of patients with advanced non-small cell lung cancer (NSCLC) and high levels of gene mutations, the drugmaker said on Wednesday.Reuters Health Information (Source: Medscape Allergy Headlines)
Proton Pump Inhibitor Use in Infants and Children Proton Pump Inhibitor Use in Infants and Children
PPIs are approved for use in pediatric patients, but these drugs have been associated with some potentially serious adverse effects. Find out what there is to know.Pediatric Pharmacotherapy (Source: Medscape Allergy Headlines)
Amgen and Allergan announce positive top-line results from comparative clinical study of ABP 798, biosimilar candidate to Rituxan ® (rituximab)
Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced positive top-line results from a comparative clinical study evaluating the efficacy and safety of ABP 798, a biosimilar candidate to Rituxan® (rituximab), compared to Rituxan in patients with CD20-positive B-cell non-Hodgkin's lymphoma. (Source: World Pharma News)
Brutal Ragweed Season Forecast
People who have allergies may be in for a rough ragweed season this summer and fall, thanks to hotter and wetter weather nationwide. (Source: WebMD Health)
Problems with the site? Please let us know.